AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma

Research Site, Duarte, California, United States

Research Site, Irvine, California, United States

Research Site, Atlanta, Georgia, United States

Research Site, Boston, Massachusetts, United States

Research Site, Ann Arbor, Michigan, United States

Research Site, St Louis, Missouri, United States

Research Site, New York, New York, United States

Research Site, Philadelphia, Pennsylvania, United States

Research Site, Fairfax, Virginia, United States

Research Site, Fitzroy, Australia

Research Site, Melbourne, Australia

Research Site, Nedlands, Australia

Research Site, Wollongong, Australia

Research Site, Salvador, Brazil

Research Site, São Paulo, Brazil

Research Site, São Paulo, Brazil

Research Site, Hamilton, Ontario, Canada

Research Site, Ottawa, Ontario, Canada

Research Site, Toronto, Ontario, Canada

Research Site, Montreal, Quebec, Canada

Research Site, Nova Scotia, Canada

Research Site, Beijing, China

Research Site, Changsha, China

Research Site, Guangzhou, China

Research Site, Shenyang, China

Research Site, Lille, France

Research Site, Nantes, France

Research Site, Essen, Germany

Research Site, Freiburg im Breisgau, Germany

Research Site, Hamburg, Germany

Research Site, Heidelberg, Germany

Research Site, Lübeck, Germany

Research Site, Nuremberg, Germany

Research Site, Tübingen, Germany

Research Site, Würzburg, Germany

Research Site, Kashiwa, Japan

Research Site, Nagoya, Japan

Research Site, Yamagata, Japan

Research Site, Badalona, Spain

Research Site, Madrid, Spain

Research Site, Madrid, Spain

Research Site, Pamplona, Spain

Research Site, Salamanca, Spain